Open AccessIn vitro assessment of the efficiency of the PIM‑1 kinase pharmacological inhibitor as a potential treatment for Burkitt's lymphoma
Author(s) -
Mona Alsubaie,
Sabine MatouNasri,
Abdullah Aljedai,
Ahmed Alaskar,
Hamad AlEidi,
Sarah Albabtain,
Khawlah Essa Aldilaijan,
Manal Alsayegh,
Ibrahim AlAbdulkareem
Publication year - 2021
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2021.12883
Subject(s) - pim1 , raji cell , oncogene , cell cycle , k562 cells , viability assay , burkitt's lymphoma , kinase , biology , apoptosis , lymphoma , cancer research , microbiology and biotechnology , phosphorylation , immunology , biochemistry , serine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom